Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia

REFERENCES

• Greider CW. TL regulation. Ann Rev Biochem 1996;65:337 – 365.
   Google Scholar
• Watson JD. Origin of concatemeric T7 DNA. Nature New Biology 1972;239:197 – 201.
   Google Scholar
• Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921 – 1929.
   Google Scholar
• Blackburn EH. Structure and function of telomeres. Nature 1991;350:569 – 573. [5] Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, et al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symposia Quantitative Biology 1994;59: 307 – 315.
   Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011 – 2015.
   Google Scholar
• Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al. The RNA component of human telomerase. Science 1995;269:1236 – 1241.
   Google Scholar
• Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 1997;88: 875 – 884.
   Google Scholar
• Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO. A mammalian telomeraseassociated protein. Science 1997;275:973 – 977.
   Google Scholar
• Broccoli D, Young JW, Lange TD. Telomerase activity in normal and malignant hematopoietic cells. Proceedings of the National Academy of Sciences USA 1995;92:9082 – 9086.
   Google Scholar
• Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Molecular and Cell Biology 1996;16:2932 – 2939.
   Google Scholar
• Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW. Telomerase activity in human breast tumors. Journal of the National Cancer Institute 1996;88:116 – 122.
   Google Scholar
• Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. The Journal of Investigative Dermatology 1996;106:759 – 765.
   Google Scholar
• Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. Journal of Immunology 1995;155:3711 – 3715.
   Google Scholar
• Rhyu MS. Telomeres, telomerase, and immortality. Journal of National Cancer Institute 1995;87:884 – 894.
   Google Scholar
• Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends in Biochemical Sciences 1996;21:387 – 391.
   Google Scholar
• Holt SE, Shay JW, Wright WE. Refining the telomeretelomerase hypothesis of aging and cancer. Nature Biotechnology 1996;14:836 – 839.
   Google Scholar
• Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR. Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnology 1996;14:615 – 619.
   Google Scholar
• Shay JW, Werbin H, Wright WE. Telomeres and telomerase in human leukemias. Leukemia 1996;10:1255 – 1261.
   Google Scholar
• Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315 – 2320.
   Google Scholar
• Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proceedings of the National Academy of Sciences USA 1994;91:2900 – 2904.
   Google Scholar
• Takatsuki K, Matsuoka M, Yamaguchi K. ATL and HTLVI- related diseases. In: Takatsuki K, editor. Adult T-cell leukemia. Oxford: Oxford University Press; 1994. p 1.
   Google Scholar
• Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of HTLV in all primary tumors of adult Tcell leukemia suggests causative role of HTLV in the disease. Proceedings of the National Academy of Sciences USA 1984;81:2534 – 2537.
   Google Scholar
• Tajima K, Kuroishi T. Estimation of incidence rate of ATL among ATLV-carriers in Kyushu, Japan. Japanese Journal of Clinical Oncology 1985;15:423 – 430.
   Google Scholar
• Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y. Clinical diversity in adult T-cell leukemia/lymphoma. Cancer Research 1985;45(Suppl.):4644 – 4645.
   Google Scholar
• Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, Tajima K, Miwa M, Shimotohono K. Multi-step carcinogenesis model for adult T-cell leukemia. Japanese Journal of Cancer Research 1989;80:191 – 195.
   Google Scholar
• Shimoyama M, and members of The Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma; a report from the lymphoma study group. British Journal of Haematology 1991;79:428 – 437.
   Google Scholar
• Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y. Telomerase activity in gastric cancer. Clinical Cancer Research 1995;55:3258 – 3262. [29] Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Tominaga S, Tsugane S, Minato K, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. Journal of Clinical Oncology 1988;6: 1088 – 1097.
   Google Scholar
• Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 1994;73:2753 – 2758.
   Google Scholar
• Uchida N, Otsuka T, Arima F, Shigematsu H, Fukuyama T, Maeda M, Sugio Y, Itoh Y, Niho Y. Correlation of telomerase activity with development and progression of adult T-cell leukemia. Leukemia Research 1999;23:311 – 316.
   Google Scholar
• Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, Yokoyama T. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clinical Cancer Research 2000;6:2696 – 2701.
   Google Scholar
• Shiratsuchi M, Muta K, Abe Y, Motomura S, Taguchi F, Takatsuki H, Uike N, Umemura T, Nawata H, Nishimura J. Clinical significance of telomerase activity in multiple myeloma. Cancer 2002;94:2232 – 2238
   Google Scholar